loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 3ad48650 75e3 4c74 9302 01b0088f164e Applno 21862 Form Suspension Drops Ophthalmic Dosage 0 1 - Drug Product Composition: Nepafenac

    Menu

    Nepafenac

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 16,053Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 21862 / DOSAGE - SUSPENSION/DROPS;OPHTHALMIC - 0.1%

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    NEPAFENAC(UNII: 0J9L7J6V8C)
    (NEPAFENAC - UNII:0J9L7J6V8C)     		NEPAFENAC1mg in 1

    Inactive Ingredients

    Ingredient Name
    Alcon Laboratories, Inc.
    BENZALKONIUM CHLORIDE(F5UM2KM3W7)
    CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)(HHT01ZNK31)
    EDETATE DISODIUM(7FLD91C86K)
    HYDROCHLORIC ACID(QTT17582CB)
    MANNITOL(3OWL53L36A)
    SODIUM CHLORIDE(451W47IQ8X)
    SODIUM HYDROXIDE(55X04QC32I)
    TYLOXAPOL(Y27PUL9H56)
    WATER(059QF0KO0R)